Transanal excision of rectal tumors using a laparoscopic stapler

1995 ◽  
Vol 38 (3) ◽  
pp. 327-328 ◽  
Author(s):  
Vincent A. De Gennaro ◽  
Theodore C. Lescher
Keyword(s):  
Transanal Excision ◽  
Rectal Tumors

Surgical Treatment of Stage I Rectal Cancer

2020 ◽  
Author(s):  
Julio Garcia-Aguilar
Keyword(s):  
Rectal Cancer ◽  
Local Recurrence ◽  
Minimally Invasive ◽  
Total Mesorectal Excision ◽  
Local Excision ◽  
Neoadjuvant Chemoradiotherapy ◽  
Transanal Excision ◽  
Resection Margins ◽  
Rectal Tumors ◽  
Mesorectal Excision

For treatment of early-stage rectal cancer, local (transanal) excision offers the advantages of lower rates of morbidity, mortality, and functional impairment in comparison with radical surgery such as total mesorectal excision (TME). Minimally invasive platforms facilitate removal of rectal tumors that are beyond the reach of conventional transanal excision techniques. The main drawback of local excision is the higher risk of local recurrence compared with TME. The risk of local recurrence is higher in patients with close resection margins, tumors penetrating beyond the submucosa, or tumors with unfavorable histologic features. In these patients, outcomes for immediate proactive TME are generally better than observation followed by reactive salvage TME in case of local recurrence. The use of neoadjuvant chemoradiotherapy may make local excision a viable option for T2 rectal tumors. As chemoradiation and local excision are being increasingly used for later-stage tumors, advances in imaging technologies will play a crucial role in facilitating careful patient selection.   This review contains 5 figures, 5 tables and 37 references Key words: endocavitary contact radiotherapy, local excision, local recurrence, rectal cancer, salvage surgery, total mesorectal excision, transanal endoscopic operation, transanal excision, transanal minimally invasive surgery  

Surgical Treatment of Stage I Rectal Cancer

2020 ◽  
Author(s):  
Julio Garcia-Aguilar
Keyword(s):  
Rectal Cancer ◽  
Local Recurrence ◽  
Minimally Invasive ◽  
Total Mesorectal Excision ◽  
Local Excision ◽  
Neoadjuvant Chemoradiotherapy ◽  
Transanal Excision ◽  
Resection Margins ◽  
Rectal Tumors ◽  
Mesorectal Excision

For treatment of early-stage rectal cancer, local (transanal) excision offers the advantages of lower rates of morbidity, mortality, and functional impairment in comparison with radical surgery such as total mesorectal excision (TME). Minimally invasive platforms facilitate removal of rectal tumors that are beyond the reach of conventional transanal excision techniques. The main drawback of local excision is the higher risk of local recurrence compared with TME. The risk of local recurrence is higher in patients with close resection margins, tumors penetrating beyond the submucosa, or tumors with unfavorable histologic features. In these patients, outcomes for immediate proactive TME are generally better than observation followed by reactive salvage TME in case of local recurrence. The use of neoadjuvant chemoradiotherapy may make local excision a viable option for T2 rectal tumors. As chemoradiation and local excision are being increasingly used for later-stage tumors, advances in imaging technologies will play a crucial role in facilitating careful patient selection.   This review contains 5 figures, 5 tables and 37 references Key words: endocavitary contact radiotherapy, local excision, local recurrence, rectal cancer, salvage surgery, total mesorectal excision, transanal endoscopic operation, transanal excision, transanal minimally invasive surgery  

The Ferguson Operating Anoscope as a Minimally Invasive Option for the Treatment of Rectal Tumors

2010 ◽  
Vol 76 (8) ◽  
pp. 850-856
Author(s):  
J. Daniel Stanley ◽  
Christopher Bell ◽  
Nathan Hinkle ◽  
Richard A. Moore ◽  
R. Phillip Burns
Keyword(s):  
Minimally Invasive ◽  
Anal Verge ◽  
Case Series ◽  
Transanal Excision ◽  
Benign Tumors ◽  
Rectal Tumors ◽  
Transient Effects ◽  
Invasive Treatment ◽  
Retrospective Case ◽  
Recurrence Rates

Transanal excision of rectal tumors may be performed using the Ferguson Operating Anoscope (FOA). This retrospective case series evaluates the effectiveness of FOA for the excision of selected benign and malignant rectal tumors. The office records of 97 patients with rectal tumors who underwent FOA transanal excision by a single surgeon from 1999 through 2009 were reviewed. In the 97 patients evaluated, 99 FOA transanal excisions were performed for 39 adenocarcinomas, 55 benign tumors, and five carcinoid tumors. The tumors were 0.5 to 13.5 cm in diameter and located an average of 6.9 cm (range, 1 to 15 cm) from the anal verge. Ninety-one per cent of cases were performed as an outpatient. Postoperative complications occurred in 14 per cent with transient effects on continence in 2 per cent and a mean blood loss of 66 mL. The recurrence rate for favorable T1 rectal cancers was 4.3 per cent and for adenomas was 5.9 per cent. In early follow up of adenomas and favorable T1 carcinomas, FOA transanal excision has similar application, morbidity, and recurrence rates as reported for transanal endoscopic microsurgery for rectal tumors within 15 cm from the anal verge. FOA may be considered a useful option for the minimally invasive treatment of rectal tumors.

Gasless Video Endoscopic Transanal Excision of Rectal Tumors Incompletely Removed by Colonoscopic Snare Polypectomy

2003 ◽  
Vol 13 (2) ◽  
pp. 99-103 ◽  
Author(s):  
Tohru Nakagoe ◽  
Hiroshi Ishikawa ◽  
Terumitsu Sawai ◽  
Takashi Tsuji ◽  
Shi-Ichi Shibasaki ◽  
...  
Keyword(s):  
Transanal Excision ◽  
Rectal Tumors ◽  
Snare Polypectomy

Glove Port Transanal Excision of Rectal Tumors an Alternative Method for Rectal Tumor Excision

2017 ◽  
Vol 27 (4) ◽  
pp. e53-e56
Author(s):  
Sridhar Dharamavaram ◽  
Dimple Sapre ◽  
Ahmed M.A. Mohammed ◽  
Krishnamurthy Badrinath
Keyword(s):  
Rectal Tumor ◽  
Transanal Excision ◽  
Rectal Tumors ◽  
Tumor Excision ◽  
Alternative Method ◽  
Glove Port
Sign in / Sign up

Export Citation Format

Share Document